Please use this identifier to cite or link to this item:
|dc.title||A rare cause of reversible unilateral third nerve palsy|
|dc.identifier.citation||Lui, N.-L., Thumboo, J., See, S.-J. (2008). A rare cause of reversible unilateral third nerve palsy. Journal of the Neurological Sciences 275 (1-2) : 188-190. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jns.2008.08.001|
|dc.description.abstract||Case report: A 59-year-old Chinese male presented in January 2007 with acute left retro-orbital headache, diplopia and left partial ptosis. Isolated left third nerve palsy was diagnosed. Imaging studies and cerebral angiography excluded a posterior communicating artery aneurysm. Anti-nuclear (titre 1/800, speckled pattern), anti-PR3, anti-Ro and anti-La antibodies were present. Sjogren's syndrome (SS) was considered in view of positive anti-Ro and La antibodies, and was confirmed with focal lymphocytic infiltrates on labial salivary gland biopsy and a positive Schirmer's test (6 mm of tear flow over 5 min). Immunosuppressive therapy was started 2 months after his initial presentation and within 2 weeks, the patient experienced an almost complete recovery of both ptosis and diplopia. He has been on tapering doses of prednisolone since and his condition remains stable. Conclusion: This patient has cranial neuropathy secondary to Sjogren's syndrome. The rapid reversibility of the oculomotor nerve palsy with immunosuppression suggests lymphocytic infiltration or autoantibodies as the cause rather than a vasculitic process, which would have led to irreversible or slowly, partially reversible ischaemic damage. © 2008 Elsevier B.V. All rights reserved.|
|dc.subject||Cranial nerve disease|
|dc.description.sourcetitle||Journal of the Neurological Sciences|
|Appears in Collections:||Staff Publications|
Show simple item record
Files in This Item:
There are no files associated with this item.
checked on Jul 31, 2021
WEB OF SCIENCETM
checked on Jul 22, 2021
checked on Jul 10, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.